Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Tata Memorial Hospital
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
M.D. Anderson Cancer Center
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
Rigshospitalet, Denmark
Centre Antoine Lacassagne
Centre Antoine Lacassagne
University of Colorado, Denver
Memorial Sloan Kettering Cancer Center
GERCOR - Multidisciplinary Oncology Cooperative Group
Cairo University
Samsung Medical Center
University of Michigan
Thomas Jefferson University